Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice

2018 ◽  
Vol 98 ◽  
pp. 553-565 ◽  
Author(s):  
Xiao-meng Shi ◽  
Hua Zhang ◽  
Zhang-jiuzhi Zhou ◽  
Ying-ying Ruan ◽  
Jie Pang ◽  
...  
2008 ◽  
Vol 6 (1-2) ◽  
pp. 29-36 ◽  
Author(s):  
Laurence Ozmen ◽  
Anita Albientz ◽  
Christian Czech ◽  
Helmut Jacobsen

SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A41-A41
Author(s):  
K Shimomura

Abstract Introduction Prior studies have shown that the gut microbiomes of Alzheimer’s Disease (AD) patients differ from unaffected individuals. Sleep and circadian rhythm disturbances are common in AD and often precede dementia symptoms. Gut microbiome alterations have also been observed in models of circadian disruption. Therefore, we hypothesized that altering the gut microbiome could improve sleep/circadian rhythms and cognition in an AD mouse model. Methods Mice were given a dietary polysaccharide, Modified Resistant Maltodextrin (MRM), as a 1% solution in the drinking water beginning at 2 months of age. 5xFAD and wild-type (WT) littermates were tested. Sleep-wake was recorded by EEG/EMG, memory consolidation was tested by the Object-Location Memory test, and beta amyloid deposition in the brain was assayed (dot blot). Composition of the gut microbiota was determined from amplicon sequencing of the 16s ribosomal RNA gene from fecal DNA. Results MRM treatment reduced dark (active)-phase sleep and the phase scattering of REM sleep in 5xFAD mice, indices of circadian consolidation. 6-month-old 5xFAD mice given plain water exhibited no 24hr retention of object location memory. However, MRM-treated 5xFAD mice demonstrated 24-hour memory, even at 12 months of age. Both improved memory and increased consolidation of sleep were also observed in WT mice. Two unclassified species of bacteria from the family Tannerellaceae were significantly increased in MRM-treated 5xFAD and WT mice. At 12 months of age, synaptic and neuronal loss become prominent in this AD model. However, the level of beta amyloid deposition in the brain was not significantly different between MRM and water control groups. Conclusion MRM treatment altered the gut microbiome, improved circadian timing of sleep and memory retention, but did not impact beta amyloid deposition in 5xFAD mice. Because these effects were also present in WT mice, MRM-induced microbiome changes may affect sleep and cognition independently from beta amyloid. Support Northwestern University Feinberg School of Medicine Center for Circadian and Sleep Medicine


PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e29790 ◽  
Author(s):  
Min Song ◽  
Jia-xiang Xiong ◽  
Yan-yan Wang ◽  
Jun Tang ◽  
Bo Zhang ◽  
...  

2013 ◽  
Vol 9 ◽  
pp. P16-P17 ◽  
Author(s):  
Laksanun Cheewakriengkrai ◽  
Jared Rowley ◽  
Sara Mohades ◽  
Thomas Beaudry ◽  
Antoine Leuzy ◽  
...  

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Tien-Phat V. Huynh ◽  
Chao Wang ◽  
Ainsley C. Tran ◽  
G. Travis Tabor ◽  
Thomas E. Mahan ◽  
...  

Abstract Background The apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset Alzheimer disease (AD). ApoE is produced by both astrocytes and microglia in the brain, whereas hepatocytes produce the majority of apoE found in the periphery. Studies using APOE knock-in and transgenic mice have demonstrated a strong isoform-dependent effect of apoE on the accumulation of amyloid-β (Aβ) deposition in the brain in the form of both Aβ-containing amyloid plaques and cerebral amyloid angiopathy. However, the specific contributions of different apoE pools to AD pathogenesis remain unknown. Methods We have begun to address these questions by generating new lines of APOE knock-in (APOE-KI) mice (ε2/ε2, ε3/ε3, and ε4/ε4) where the exons in the coding region of APOE are flanked by loxP sites, allowing for cell type-specific manipulation of gene expression. We assessed these mice both alone and after crossing them with mice with amyloid deposition in the brain. Using biochemical and histological methods. We also investigated how removal of APOE expression from hepatocytes affected cerebral amyloid deposition. Results As in other APOE knock-in mice, apoE protein was present predominantly in astrocytes in the brain under basal conditions and was also detected in reactive microglia surrounding amyloid plaques. Primary cultured astrocytes and microglia from the APOE-KI mice secreted apoE in lipoprotein particles of distinct size distribution upon native gel analysis with microglial particles being substantially smaller than the HDL-like particles secreted by astrocytes. Crossing of APP/PS1 transgenic mice to the different APOE-KI mice recapitulated the previously described isoform-specific effect (ε4 > ε3) on amyloid plaque and Aβ accumulation. Deletion of APOE in hepatocytes did not alter brain apoE levels but did lead to a marked decrease in plasma apoE levels and changes in plasma lipid profile. Despite these changes in peripheral apoE and on plasma lipids, cerebral accumulation of amyloid plaques in APP/PS1 mice was not affected. Conclusions Altogether, these new knock-in strains offer a novel and dynamic tool to study the role of APOE in AD pathogenesis in a spatially and temporally controlled manner.


2012 ◽  
Vol 8 (4S_Part_20) ◽  
pp. S744-S744
Author(s):  
Ayodeji Asuni ◽  
Xu Kevin Lin ◽  
Maitea Guridi ◽  
Sandrine Sanchez ◽  
Bijan Almassian ◽  
...  

2010 ◽  
Vol 112 (6) ◽  
pp. 1404-1416 ◽  
Author(s):  
Yan Lu ◽  
Xu Wu ◽  
Yuanlin Dong ◽  
Zhipeng Xu ◽  
Yiying Zhang ◽  
...  

Background Recent studies have suggested that children undergoing surgery under anesthesia could be at an increased risk for the development of learning disabilities, but whether anesthetics contribute to this learning disability is unclear. Therefore, the authors set out to assess the effects of sevoflurane, the most commonly used inhalation anesthetic, on caspase activation, apoptosis, beta-amyloid protein levels, and neuroinflammation in the brain tissues of neonatal naïve and Alzheimer disease (AD) transgenic mice. Methods Six-day-old naïve and AD transgenic (B6.Cg-Tg[amyloid precursor protein swe, PSEN1dE9]85Dbo/J) mice were treated with sevoflurane. The mice were killed at the end of the anesthesia, and the brain tissues were harvested and then subjected to Western blot, immunocytochemistry, enzyme-linked immunosorbent assay, and real-time polymerase chain reaction. Results Herein, the authors show for the first time that sevoflurane anesthesia induced caspase activation and apoptosis, altered amyloid precursor protein processing, and increased beta-amyloid protein levels in the brain tissues of neonatal mice. Furthermore, sevoflurane anesthesia led to a greater degree of neurotoxicity in the brain tissues of the AD transgenic mice when compared with naïve mice and increased tumor necrosis factor-alpha levels in the brain tissues of only the AD transgenic mice. Finally, inositol 1,4,5-trisphosphate receptor antagonist 2-aminoethoxydiphenyl borate attenuated sevoflurane-induced caspase-3 activation and beta-amyloid protein accumulation in vivo. Conclusion These results suggest that sevoflurane may induce neurotoxicity in neonatal mice. AD transgenic mice could be more vulnerable to such neurotoxicity. These findings should promote more studies to determine the potential neurotoxicity of anesthesia in animals and humans, especially in children.


Sign in / Sign up

Export Citation Format

Share Document